Supplemental material
Leukemia & Lymphoma
Volume 59, 2018 - Issue 11
Correspondence
Rituximab addition to chemotherapy in real world patients with chronic lymphocytic leukemia: effective in first line but indication of lack of efficacy in subsequent lines of therapy
Lina van der StratenDepartment of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands; Correspondence[email protected]
http://orcid.org/0000-0002-9359-1203
http://orcid.org/0000-0002-9359-1203, Avinash G. DinmohamedDepartment of Research, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands; ;Department of Public Health, Erasmus University Medical Centre, Rotterdam, The Netherlands; ;Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands; http://orcid.org/0000-0002-4767-6716
http://orcid.org/0000-0002-4767-6716, , , , , & show all